Workflow
Revvity(RVTY) - 2025 Q1 - Earnings Call Presentation

Financial Performance - Q1 2025 - Revenue reached $665 million, showing a 2% year-over-year increase[10] - Organic revenue growth was 4%, while foreign exchange had a negative impact of 1%[10] - Adjusted operating margin stood at 25.6%, a slight increase of 5 basis points year-over-year[10] - Adjusted EPS was $1.01, representing a 4% year-over-year increase[10] - Free cash flow was $118 million, with a free cash flow percentage of adjusted net income at 97%[10] Segment Performance - Q1 2025 - Life Sciences revenue was $340 million, with organic growth of 2%[12, 13] - Diagnostics revenue was $324 million, with organic growth of 5%[15, 16] Full Year 2025 Guidance - Revenue is projected to be between $2.83 billion and $2.87 billion, representing reported growth of 3% to 4%[17] - Organic revenue growth is expected to be between 3% and 5%[17] - Adjusted operating margin is guided to be between 27.9% and 28.1%[17] - Adjusted EPS is projected to be between $4.90 and $5.00[17]